MEDICINES CO's ticker is and the CUSIP is 584688AG0.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $24,415,000 | +43.6% | 14,000,000 | 0.0% | 0.12% | +30.1% |
Q3 2019 | $17,008,000 | +23.8% | 14,000,000 | 0.0% | 0.09% | +22.4% |
Q2 2019 | $13,735,000 | +16.9% | 14,000,000 | 0.0% | 0.08% | +4.1% |
Q1 2019 | $11,754,000 | +12.4% | 14,000,000 | 0.0% | 0.07% | +5.8% |
Q4 2018 | $10,456,000 | -25.0% | 14,000,000 | -8.2% | 0.07% | -10.4% |
Q3 2018 | $13,935,000 | -9.0% | 15,250,000 | 0.0% | 0.08% | -18.1% |
Q2 2018 | $15,321,000 | +3.1% | 15,250,000 | 0.0% | 0.09% | -3.1% |
Q1 2018 | $14,867,000 | +6.0% | 15,250,000 | 0.0% | 0.10% | +36.6% |
Q4 2017 | $14,025,000 | -12.7% | 15,250,000 | 0.0% | 0.07% | -42.7% |
Q3 2017 | $16,057,000 | +0.1% | 15,250,000 | 0.0% | 0.12% | +4.2% |
Q2 2017 | $16,036,000 | – | 15,250,000 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Man Investments (CH) AG | 3,000,000 | $2,762,000 | 2.59% |
PT ASSET MANAGEMENT, LLC | 3,750,000 | $3,448,000 | 1.87% |
ARISTEIA CAPITAL, L.L.C. | 32,500,000 | $29,921,000 | 1.27% |
ZAZOVE ASSOCIATES LLC | 22,710,000 | $20,905,000 | 1.23% |
PFM Health Sciences, LP | 34,471,000 | $31,692,000 | 0.75% |
CAPSTONE INVESTMENT ADVISORS, LLC | 24,215,000 | $22,262,000 | 0.63% |
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 36,000,000 | $33,075,000,000 | 0.59% |
Partner Investment Management, L.P. | 479,000 | $440,000 | 0.51% |
SSI INVESTMENT MANAGEMENT LLC | 4,808,000 | $4,398,000 | 0.37% |
WOLVERINE ASSET MANAGEMENT LLC | 32,315,000 | $29,732,000 | 0.30% |